PPT-Access to Controlled Medicines

Author : alexa-scheidler | Published Date : 2018-02-16

Willem Scholten PharmD MPA Team Leader Access to Controlled Medicines World Health Organization Geneva Switzerland TECHNICAL BRIEFING SEMINAR Geneva 29 October

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Access to Controlled Medicines" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Access to Controlled Medicines: Transcript


Willem Scholten PharmD MPA Team Leader Access to Controlled Medicines World Health Organization Geneva Switzerland TECHNICAL BRIEFING SEMINAR Geneva 29 October 2 November 2012 Overview. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Dr Duncan Petty. Lecturer Practitioner. School of Health Care, University of Leeds. RCN Advanced Nurse Practitioner. Forum conference 2011. 10 top tips for safer prescribing and review of medicines. Dr Duncan Petty. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . Willem Scholten, PharmD, MPA. Team Leader, Access to Controlled Medicines,. World Health Organization, Geneva, Switzerland. TECHNICAL BRIEFING SEMINAR . Geneva, 29 October – 2 November 2012. Overview. Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). PARTNERSHIP. Medicines for Europe Vision 2020 . Our 5 pillars. 2. PATIENTS. Medicines For Europe . VISION. QUALITY. VALUE. SUSTAINABILITY. Pressure on EU budgets . Reduction. of . healthcare. . spending. WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). 1997. Some practical tips. Jason Hale CLE Legal Aid NSW. Hunter Street Chambers Newcastle. www.hunterstreetchambers.com.au 11 March 2015. Three points for today…. The Authority to conduct the controlled operation. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Willem Scholten, PharmD, MPA. Team Leader, Access to Controlled Medicines,. World Health Organization, Geneva, Switzerland. TECHNICAL BRIEFING SEMINAR . Geneva, 29 October – 2 November 2012. Overview. Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament  . PI: Deanne Rogers / SUNY Stony Brook University . http://cpex.labs.stonybrook.edu/drogers/. Planetary . Science Legacy . Facilities . Description of Facility. The CEC is a glove box equipped with a relative humidity and temperature control system that permits experiments, spectral measurements and XRD measurements of RH/T-sensitive samples. Controlled Temperature Range: -25°C to Ambient .

Download Document

Here is the link to download the presentation.
"Access to Controlled Medicines"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents